The Wall Street Journal featured FDNA’s Face2Gene in an August 2026 article examining how artificial intelligence is helping patients and clinicians investigate rare and difficult-to-identify medical conditions.
The article tells the story of Rachel Hinken and her son Oliver, whose healthcare journey eventually led to the use of Face2Gene. The technology identified Trichorhinophalangeal syndrome (TRPS) as a strong match, which was subsequently confirmed through genetic testing and clinical evaluation. Testing also showed that Rachel had TRPS.
The broader article explores how AI tools can help surface potential rare conditions that clinicians may encounter infrequently, while emphasizing that these technologies should support, rather than replace, clinical evaluation and human interpretation.
Read the original article: AI Is Helping Patients Solve Medical Mysteries, The Wall Street Journal, Alex Janin, August 15, 2026
